{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Rockford",
      "address_1": "4901 Hiawatha Dr",
      "reason_for_recall": "Correct Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may have been mis-packaged in a carton labeled Doxorubicin Hydrochloride Injection 2 mg/mL, 100 mL",
      "address_2": "",
      "product_quantity": "936 vials",
      "code_info": "Lot Number: 7801009; Exp: Apr-2015",
      "center_classification_date": "20150313",
      "distribution_pattern": "Nationwide",
      "state": "IL",
      "product_description": "DOXOrubicin Hydrochloride Injection, USP, 200 mg/100 mL (2 mg/mL), For IV Use Only, Sterile, ISOTONIC SOLUTION, Caution: Cytotoxic Agent, 100 mL Multi-Dose Vial, Rx Only, Manufactured By: Onco Therapies Limited, Bangalore, 560105, INDIA, Distributed By: Amneal-Agila, LLC, Glasgow, KY, 42141, NDC 53150-317-01.",
      "report_date": "20150325",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Mylan Institutional LLC",
      "recall_number": "D-0412-2015",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "70565",
      "termination_date": "20160209",
      "more_code_info": "",
      "recall_initiation_date": "20150211",
      "postal_code": "61103-1287",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}